Annual report pursuant to Section 13 and 15(d)

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.23.1
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF EFFECTS OF THE RESTATEMENT TO AMOUNTS IN THE PREVIOUSLY REPORTED CONSOLIDATED FINANCIAL STATEMENTS

A reconciliation of the effects of the restatement to amounts in the previously reported consolidated financial statements for the year ended December 31, 2021 are as follows (in thousands):

                         
    As of December 31, 2021  
Consolidated Balance Sheet   As Reported     Adjustment     As Revised  
                   
Total assets   $ 79,586     $     $ 79,586  
Total liabilities     28,211       9,007       37,218  
Total stockholders’ equity     51,375       (9,007 )     42,368  
Accumulated deficit     (655,640 )           (655,640 )

 

    As of December 31, 2021  
Consolidated Statement of Stockholders’ Equity   As Reported     Adjustment     As Revised  
                   
Additional paid-in capital, December 31, 2021   $ 705,570     $ (9,007 )   $ 696,563  
Total stockholders’ equity, December 31, 2021     51,375       (9,007 )     42,368  
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

    For the year ended December 31,  
    2022     2021  
             
Stock options     240,770       317,394  
Restricted stock     816,958       97,261  
Warrants     9,397,879       1,788,000  
Total     10,455,607       2,202,655